One of these cannabis ETFs is a clear buy – but avoid the other at all costs…
There’s only one type of investment that gives you access to the moneymaking potential of the cannabis industry’s biggest movers and shakers, all in one fell swoop…
And that’s with exchange-traded funds (or ETFs).
ETFs are funds that own a basket of stocks, commodities, or bonds. They allow investors to have broad access to a bunch of companies in a given sector.
Just like individual stocks, they can be bought and sold throughout the day. But, like individual stocks, there are winners – and there are wannabes.
The right ETF can give you exposure to the leading multistate operators (MSOs) that are capitalizing on the $20 billion-and-growing United States cannabis market…
Names like Green Thumb Industries (OTC: GTBIF), Curaleaf Holdings Inc. (OTC: CURLF), Cresco Labs Inc. (OTC: CRLBF), and Trulieve Cannabis Corp. (OTC: TCNNF) that are seeing incredible sales growth quarter after quarter and posting record revenues.
The wrong ETF, on the other hand, will give you exposure to the lagging Canadian operators that are stuck competing over Canada‘s comparably meager $2.6 billion cannabis market…
Names like Canopy Growth Corp. (NYSE: CGC), Aurora Cannabis Inc. (Nasdaq: ACB), and Cronos Group Inc. (Nasdaq: CRON) that have been featured in our Sell of the Week series because they simply don’t have what it takes to make you money compared to their American counterparts.
That’s why I’m here to help you tell the difference between the leaders and the laggards with a brand-new episode of Buy or Sell all about cannabis ETFs.
And in case you missed it, make sure you also check out the premiere episode of our Buy or Sell series, which reveals the best and worst of Florida cannabis stocks.
To your investing success,
Executive Director, National Institute for Cannabis Investors
August 31 2021